Policy

Report: Purdue Pharma to Plead Guilty to 3 Federal Charges
In an $8 billion settlement, the maker of OxyContin will plead guilty to charges that include providing false information to the DEA and giving kickbacks to doctors for writing unnecessary prescriptions. Critics, however, argue the plea agreement does not sufficiently penalize the company’s leadership.
BH Providers Can Now Apply for Phase 3 Provider Relief Fund Payments
Financially strapped behavioral healthcare providers impacted by COVID-19 can now apply for relief through the Provider Relief Fund, HHS has announced. Applications are being accepted through Nov. 6.
345 Charged in Record-Setting Opioid Takedown by Justice Department
The U.S. Department of Justice announced a nationwide takedown of 345 charged defendants—including more than 100 doctors, nurses and other licensed medical professionals—on suspicion of submitting more than $6 billion in false and fraudulent claims to federal healthcare programs and private insurers.
National Council Unveils Success Center to Support CCBHCs
National Council has announced the launch of an online resource as part of its plan to expand Certified Community Behavioral Health Clinics, as well as a guide for behavioral health providers to integrate general health services into their settings.
California Awards $20 Million to Hospitals to Fund SUD Treatment Services
The California Department of Health Care Services has announced that $20 million in funding will be awarded to two-thirds of hospitals in the state to provide opioid and substance use disorder treatment services.
DEA Announces Two Historic Drug Busts in Southern California
Authorities in Los Angeles and San Diego have conducted record-setting seizures of cocaine, heroin, crystal meth and fentanyl within the past two weeks.
FDA Seeks Public Input on Patient-Focused Drug Development for Stimulant Use Disorder
The FDA will conduct a virtual public meeting on patient-focused drug development for stimulant use disorder on Oct. 6, and is seeking input from individuals and families impacted by stimulant use.
State and County Budget Shortfalls to Reach Almost $650 Billion
State, county and local government financial shortfalls are reaching dangerous levels as these entities continue to respond to the COVID-19 pandemic.
HEAL Initiative Slowed by COVID-19, but NIH Still Making Advances
With much of the research in the Helping to End Addiction Long-term Initiative temporarily on pause, NIH Director Francis Collins, MD, PhD, and Nora Volkow, MD, director of the National Institute on Drug Abuse, shared with Rx Summit attendees other areas of progress for NIH.
'Agenda for Change' Conference Brings Big-Picture Issues Back Into Focus
The event, held last week in Washington, D.C., served as a state of the union for behavioral healthcare, drawing attention to the largest issues facing the field.
CBD Summit Identifies a Course of Action
Identification of a more rapid pathway for research on cannabinoids and a separate pathway for research on over-the-counter products were among the topics discussed by Summit speakers.

Videos

Video: ONC’s Scott Weinstein outlines the Data Segmentation for Privacy (DS4P) initiative

ONC fellow discusses current privacy initiatives being explored in federal health IT effort

Back to Top